Puerarin Decreases the Expression of FUS‐Dependent MAPK4 to Inhibit the Development of Triple‐Negative Breast Cancer

Documenti analoghi

• Discovery of New 4‐Aminoquinoline–Thiazolidinone Hybrid Analogs as Antiproliferative Agents Inhibiting TLR4–LPS‐Mediated Migration in Triple‐Negative Breast Cancer Cells
  di: S. K. Batin Rahaman, et al.
  Pubblicazione: (2025)
• Bruceine A Suppresses Triple‐Negative Breast Cancer Growth and Metastasis by Inducing GPX4 ‐Dependent Ferroptosis via Ubiquitin–Proteasome‐Mediated Degradation
  di: Hengguan Cui, et al.
  Pubblicazione: (2026)
• Selective Antiproliferative and Apoptotic Effects of 2,6‐Diketopiperazines on MDA‐MB‐231 Triple‐Negative Breast Cancer
  di: Flor Paulina Garrido González, et al.
  Pubblicazione: (2025)
• Oridonin Alleviates Doxorubicin‐Induced Cardiotoxicity by Inhibiting p38 MAPK/MMP3 Signaling Pathway
  di: Xingyuan Hou, et al.
  Pubblicazione: (2025)
• Dehydroepiandrosterone‐α‐2‐Deoxyglucoside Exhibits Enhanced Anticancer Effects in MCF‐7 Breast Cancer Cells and Inhibits Glucose‐6‐Phosphate Dehydrogenase Activity
  di: Hsu‐Feng Liu, et al.
  Pubblicazione: (2024)